The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.
Rituximab-Treated Patients Have a Poor Response to Influenza Vaccination
Open accessAbstract
The efficacy of influenza vaccination in patients treated with rituximab is a clinically important question. Rheumatology clinics are populated with patients receiving rituximab for a broad array of disorders. Although several studies have explored the efficacy of other vaccines in rituximab-treated populations, results have been conflicting. We wished to define influenza vaccine efficacy in a rituximab-treated cohort. We examined 17 evaluable subjects treated with rituximab for rheumatologic conditions. T cell subsets, B cells subsets, T cell function, and B cell function were evaluated at specific time points along with hemagglutinination inhibition titers after receiving the standard inactivated influenza vaccine. T cell subset counts were significantly different than controls but did not change with rituximab. B cells depleted in all patients but were in various stages of recovery at the time of vaccination. Influenza vaccine responsiveness was poor overall, with only 16 % of subjects having a four-fold increase in titer. Pre-existing titers were retained throughout the study, however. The ability to respond to the influenza vaccine appeared to be related to the degree of B cell recovery at the time of vaccination. This study emphasizes that antibody responses to vaccine are impaired in subjects treated with rituximab and supports the concept that B cell recovery influences influenza vaccine responsiveness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The degree of B-cell recovery at the time of vaccination correlated with the extent of the humoral response to vaccination, as reported for influenza vaccine in patients with RA treated with rituximab.38”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673
Bongartz, T., Sutton, A. J., Sweeting, M. J., Buchan, I. E., Matteson, E. L., & Montori, V. M. (2006) · JAMA · doi:10.1001/jama.295.19.2275 · Cited by 2,470
Influenza-Associated Hospitalizations in the United States
Thompson, W. W. (2004) · JAMA · doi:10.1001/jama.292.11.1333 · Cited by 2,213
Fiore, A. E., Uyeki, T. M., Broder, K. R., Finelli, L., Euler, G. L., Singleton, J. A., Iskander, J. K., Wortley, P. M., Shay, D. K., Bresee, J., et al. (2009) · PubMed · Cited by 1,964
Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009
Jain, S., Kamimoto, L., Bramley, A. M., Schmitz, A. M., Benoit, S. R., Louie, J., Sugerman, D. E., Druckenmiller, J. K., Ritger, K. A., Chugh, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906695 · Cited by 1,700
Doran, M. F., Crowson, C. S., Pond, G. R., O’Fallon, W. M., & Gabriel, S. E. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10524 · Cited by 1,213
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans
Querec, T. D., Akondy, R. S., Lee, E. K., Cao, W., Nakaya, H. I., Teuwen, D. E., Pirani, A. M., Gernert, K. M., Deng, J., Marzolf, B., et al. (2008) · Nature Immunology · doi:10.1038/ni.1688 · Cited by 1,123
The Efficacy of Influenza Vaccine in Elderly Persons: A Meta-Analysis and Review of the Literature
Gross, P. A., Hermogenes, A. W., Sacks, H. S., Lau, J., & Levandowski, R. A. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-7-199510010-00008 · Cited by 1,100
Neuzil, K. M., Mellen, B. G., Wright, P. F., Mitchel, E. F., & Griffin, M. R. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001273420401 · Cited by 1,099
(2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03793.x · Cited by 957
Cited by
Sorted by citations
Furer, V., Rondaan, C., Heijstek, M. W., Agmon‐Levin, N., van Assen, S., Bijl, M., Breedveld, F. C., D’Amelio, R., Dougados, M., Kapetanovic, M. C., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215882 · Cited by 859
Furer, V., Eviatar, T., Zisman, D., Peleg, H., Paran, D., Levartovsky, D., Zisapel, M., Elalouf, O., Kaufman, I., Meidan, R., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-220647 · Cited by 654
Apostolidis, S. A., Kakara, M., Painter, M. M., Goel, R. R., Mathew, D., Lenzi, K., Rezk, A., Patterson, K. R., Espinoza, D. A., Kadri, J. C., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01507-2 · Cited by 506
Self-citationEffect of ocrelizumab on vaccine responses in patients with multiple sclerosis
Bar‐Or, A., Calkwood, J., Chognot, C., Evershed, J., Fox, E., Herman, A. E., Manfrini, M., McNamara, J., Robertson, D. S., Stokmaier, D., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000010380 · Cited by 339
Bhoj, V. G., Arhontoulis, D. C., Wertheim, G. B. W., Capobianchi, J., Callahan, C. A., Ellebrecht, C. T., Obstfeld, A. E., Lacey, S. F., Melenhorst, J. J., Nazimuddin, F., et al. (2016) · Blood · doi:10.1182/blood-2016-01-694356 · Cited by 282
Ullmann, A. J., Schmidt‐Hieber, M., Bertz, H., Heinz, W., Kiehl, M. G., Krüger, W., Mousset, S., Neuburger, S., Neumann, S., Penack, O., et al. (2016) · Annals of Hematology · doi:10.1007/s00277-016-2711-1 · Cited by 214
Leandro, M. J. (2013) · Arthritis Research & Therapy · doi:10.1186/ar3908 · Cited by 214
Galmiche, S., Nguyen, L. B. L., Tartour, É., de Lamballerie, X. N., Wittkop, L., Loubet, P., & Launay, O. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.09.036 · Cited by 207
The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis
Winthrop, K. L., Silverfield, J., Racewicz, A., Neal, J., Lee, E. B., Hrycaj, P., Gomez-Reino, J., Soma, K., Mebus, C., Wilkinson, B., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-207191 · Cited by 196
The effect of rituximab on vaccine responses in patients with immune thrombocytopenia
Nazi, I., Kelton, J. G., Larché, M., Snider, D. P., Heddle, N. M., Crowther, M. A., Cook, R. J., Tinmouth, A. T., Mangel, J. E., & Arnold, D. M. (2013) · Blood · doi:10.1182/blood-2013-04-494096 · Cited by 192
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma
Perry, C., Luttwak, E., Balaban, R., Shefer, G., Morales, M., Aharon, A., Tabib, Y., Cohen, Y. C., Benyamini, N., Beyar‐Katz, O., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021005094 · Cited by 153
Marco, H., Smith, R., Jones, R. B., Guerry, M., Catapano, F., Burns, S., Chaudhry, A., Smith, K. G. C., & Jayne, D. R. W. (2014) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-15-178 · Cited by 148
Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies
Papp, K. A., Haraoui, B. P., Kumar, D., Marshall, J. K., Bissonnette, R., Bitton, A., Bressler, B. L., Gooderham, M., HO, V. C., Jamal, S., et al. (2018) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/1203475418811335 · Cited by 124
CD20 as a gatekeeper of the resting state of human B cells
Kläsener, K., Jellusova, J., Andrieux, G., Salzer, U., Böhler, C., Steiner, S. N., Albinus, J. B., Cavallari, M., Süß, B., Voll, R. E., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2021342118 · Cited by 115
Rituximab in autoimmune diseases
Randall, K. L. (2016) · Australian Prescriber · doi:10.18773/austprescr.2016.053 · Cited by 118
Consequences of B-Cell-Depleting Therapy: Hypogammaglobulinemia and Impaired B-Cell Reconstitution
Sacco, K. A., & Abraham, R. S. (2018) · Immunotherapy · doi:10.2217/imt-2017-0178 · Cited by 113
Adverse reactions to biologic agents and their medical management
Boyman, O., Comte, D., & Spertini, F. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.123 · Cited by 117
B-cell targeted therapeutics in clinical development
Blüml, S., McKeever, K., Ettinger, R., Smolen, J. S., & Herbst, R. (2013) · Arthritis Research & Therapy · doi:10.1186/ar3906 · Cited by 114
Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients
Vijenthira, A., Gong, I. Y., Betschel, S., Cheung, M. C., & Hicks, L. K. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021004629 · Cited by 108
Benjamini, O., Rokach, L., Itchaki, G., Braester, A., Shvidel, L., Goldschmidt, N., Shapira, S., Dally, N., Avigdor, A., Rahav, G., et al. (2021) · Haematologica · doi:10.3324/haematol.2021.279196 · Cited by 98
Can Immune Thrombocytopenia Be Cured with Medical Therapy?
Prak, E. T. L., Cines, D. B., & Cuker, A. C. (2015) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0034-1544001 · Cited by 88
Self-citationYasuda, H., Tsukune, Y., Watanabe, N., Sugimoto, K., Uchimura, A., Tateyama, M., Miyashita, Y., Ochi, Y., & Komatsu, N. (2020) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2020.08.017 · Cited by 82
Kapetanovic, M. C., Kristensen, L., Saxne, T., Aktas, T., Mörner, A., & Geborek, P. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4427 · Cited by 81
Schietzel, S., Anderegg, M. A., Limacher, A., Born, A., Horn, M. P., Maurer, B., Hirzel, C., Sidler, D., & Moor, M. B. (2022) · RMD Open · doi:10.1136/rmdopen-2021-002036 · Cited by 68
Cho, A., Bradley, B., Kauffman, R. C., Priyamvada, L., Kovalenkov, Y. O., Feldman, R. J., & Wrammert, J. (2017) · JCI Insight · doi:10.1172/jci.insight.93222 · Cited by 68
Reddy, V. R., Martínez, L., Isenberg, D. A., Leandro, M. J., & Cambridge, G. (2016) · Arthritis Care & Research · doi:10.1002/acr.22993 · Cited by 67
Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?
Houot, R., Levy, R., Cartron, G., & Armand, P. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.06.017 · Cited by 59
Tzioufas, A. G., Bakasis, A., Goules, A. V., Bitzogli, K., Cinoku, I. I., Chatzis, L. G., Argyropoulou, O. D., Venetsanopoulou, A. I., Mavrommati, M., Stergiou, I. Ε., et al. (2021) · Journal of Autoimmunity · doi:10.1016/j.jaut.2021.102743 · Cited by 62
Labella, A. M., & Merel, S. E. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2013.03.001 · Cited by 61
Ariza‐Heredia, E., Gulbis, A. M., Stolar, K. R., Kebriaei, P., Shah, D. P., McConn, K., Champlin, R. E., & Chemaly, R. F. (2014) · Transplant Infectious Disease · doi:10.1111/tid.12312 · Cited by 60
Rituximab for immunologic renal disease: What the nephrologist needs to know
Kronbichler, A., Windpessl, M., Pieringer, H., & Jayne, D. R. W. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.04.007 · Cited by 55
Haskin, O., Ashkenazi‐Hoffnung, L., Ziv, N., Borovitz, Y., Dagan, A., Levi, S. S., Koren, G., Hamdani, G., Erez, D. L., Landau, D., et al. (2021) · Transplantation · doi:10.1097/tp.0000000000003922 · Cited by 52
Safety issues of biologics in pregnant patients with rheumatic diseases
Østensen, M. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12456 · Cited by 52
Immune cell repertoires in breast cancer patients after adjuvant chemotherapy
Gustafson, C. E., Jadhav, R. R., Cao, W., Qi, Q., Pegram, M. D., Tian, L., Weyand, C. M., & Goronzy, J. J. (2020) · JCI Insight · doi:10.1172/jci.insight.134569 · Cited by 50
An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology
Gresham, L. M., Marzario, B., Dutz, J. P., & Kirchhof, M. G. (2021) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2021.01.047 · Cited by 49
Recommendations for the use of COVID-19 vaccines in patients with immune-mediated kidney diseases
Kronbichler, A., Anders, H., Juarez, G. M. F., Floege, J., Goumenos, D. S., Segelmark, M., Tesař, V., Türkmen, K., van Kooten, C., & Bruchfeld, A. N. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab064 · Cited by 46
Cohen, D., Krauthammer, S. H., Cohen, Y. C., Perry, C., Avivi, I. M., Herishanu, Y., & Even‐Sapir, E. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05389-x · Cited by 43
Soy, M., Keser, G., Atagündüz, P., Mutlu, M. Y., Gündüz, A., Köybaşı, G., & Beş, C. (2021) · Clinical Rheumatology · doi:10.1007/s10067-021-05700-z · Cited by 39
Perini, G. F., Fischer, T. R. D. C., Gaiolla, R. D., Rocha, T. B., Bellesso, M., Teixeira, L. L. C., Delamain, M. T., Scheliga, A. A. D. S., Ribeiro, G., Neto, J. V. P., et al. (2020) · Hematology Transfusion and Cell Therapy · doi:10.1016/j.htct.2020.04.002 · Cited by 36
MENACTRIMS practice guideline for COVID-19 vaccination in patients with multiple sclerosis
Yamout, B., Zakaria, M. F., Inshasi, J. S. S., Al-Jumah, M., Zeineddine, M. M., Dahdaleh, M., Bohlega, S., Gouider, R., & Alroughani, R. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103225 · Cited by 33
Magliulo, D., Wade, S. D., & Kyttaris, V. C. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108897 · Cited by 33
Lupus, vaccinations and COVID-19: What we know now
Mason, A., Anver, H., Lwin, M., Holroyd, C. R., Faust, S. N., & Edwards, C. J. (2021) · Lupus · doi:10.1177/09612033211024355 · Cited by 29
Tolf, A., Wiberg, A., Müller, M., Nazir, F. H., Pavlović, I., Laurén, I., Mangsbo, S. M., & Burman, J. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.11497 · Cited by 32
Duwe, S. C., Schmidt, B., Gärtner, B. C., Timm, J., Adams, O., Fickenscher, H., & Schmidtke, M. (2021) · PubMed Central · doi:10.3205/id000071 · Cited by 28
Ferreira, I., & Isenberg, D. A. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205246 · Cited by 29
Bačová, B., Kohutová, Z., Zubata, I. K., Gahérová, Ľ., Kučera, P., Heizer, T., Mikesova, M., Karel, T., & Novák, J. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-022-00809-0 · Cited by 26
Protecting Pediatric Oncology Patients From Influenza
Kersun, L. S., Reilly, A. F., Coffin, S. E., & Sullivan, K. E. (2013) · The Oncologist · doi:10.1634/theoncologist.2012-0401 · Cited by 26
Self-citationFatal Cache Valley virus meningoencephalitis associated with rituximab maintenance therapy
Yang, Y., Qiu, J., Snyder‐Keller, A., Wu, Y., Sun, S., Sui, H., Dean, A. B., Kramer, L. D., & Hernandez‐Ilizaliturri, F. J. (2017) · American Journal of Hematology · doi:10.1002/ajh.25024 · Cited by 25
Efficacy of inactivated vaccines in patients treated with immunosuppressive drug therapy
Bemben, N. M., & Berg, M. L. (2022) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2671 · Cited by 24
Lee, A. R. Y. B., Wong, S. Y., & Tay, S. H. (2022) · Vaccines · doi:10.3390/vaccines10050668 · Cited by 24
Shields, A. M., Venkatachalam, S., Shafeek, S., Paneesha, S., Ford, M., Sheeran, T. P., Kelly, M., Qureshi, I., Salhan, B., Karim, F., et al. (2021) · Clinical & Experimental Immunology · doi:10.1093/cei/uxab018 · Cited by 23
Multi-Omics Studies towards Novel Modulators of Influenza A Virus–Host Interaction
Söderholm, S., Fu, Y., Gaelings, L., Belanov, S., Yetukuri, L., Berlinkov, M. V., Cheltsov, A. V., Anders, S., Aittokallio, T. A., Nyman, T. A., et al. (2016) · Viruses · doi:10.3390/v8100269 · Cited by 23
Kreitman, R. J., & Pastan, I. H. (2019) · The Oncologist · doi:10.1634/theoncologist.2019-0370 · Cited by 22
Molica, S., Giannarelli, D., Lentini, M., Zappalà, D., Mannella, A., Loiacono, D., Gianfelici, V., Panduri, G., Gariani, I., Minchella, P., et al. (2021) · Chemotherapy · doi:10.1159/000521229 · Cited by 21
Tang, K., Wei, Z., & Wu, X. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27956 · Cited by 21
Knight, A., Pauksens, K., Nordmark, G., & Kumlien, E. (2017) · Lara D. Veeken · doi:10.1093/rheumatology/kew495 · Cited by 21
Diks, A. M., Overduin, L. A., van Leenen, L. D., Slobbe, L., Jolink, H., Visser, L. G., van Dongen, J. J. M., & Berkowska, M. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.690328 · Cited by 21
Cheng, D. R., Barton, R., Greenway, A. L., & Crawford, N. W. (2016) · Expert Review of Vaccines · doi:10.1080/14760584.2016.1193438 · Cited by 20
Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis
Menge, T., Dubey, D., Warnke, C., Hartung, H.-P., & Stüve, O. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1227242 · Cited by 19
Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis
Woopen, C., Schleußner, K., Akgün, K., & Ziemssen, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.701752 · Cited by 20
Law, M. F., Ho, R., Law, K. W. T., & Cheung, C. K. M. (2021) · World Journal of Hepatology · doi:10.4254/wjh.v13.i12.1850 · Cited by 21
Welte, T., Westermann, L., Kappes, J., Schramm, M. A., Bemtgen, X., Staudacher, D. L., Hug, M. J., Venhoff, N., & Arnold, F. (2023) · Arthritis & Rheumatology · doi:10.1002/art.42625 · Cited by 17
Sood, A., Tran, M., Murthy, V., & González, E. B. (2022) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000001871 · Cited by 18
Vaccinations in children on immunosuppressive medications for renal disease
Banerjee, S., Dissanayake, P., & Abeyagunawardena, A. S. (2015) · Pediatric Nephrology · doi:10.1007/s00467-015-3219-y · Cited by 16
Lakota, K., Pirkmajer, K. P., Sodin‐Šemrl, S., Čučnik, S., Šubelj, V., Prosenc, K., Mrak‐Poljšak, K., Tomšič, M., Ambrožič, A., & Praprotnik, S. (2019) · Clinical Rheumatology · doi:10.1007/s10067-019-04439-y · Cited by 16
How to use biologic agents in patients with rheumatoid arthritis who have comorbid disease
Richards, J., Dowell, S., Quiñones, M., & Kerr, G. (2015) · British medical journal · doi:10.1136/bmj.h3658 · Cited by 15
The Influence of B Cell Depletion Therapy on Naturally Acquired Immunity to Streptococcus pneumoniae
Ercoli, G., Ramos‐Sevillano, E., Nakajima, R., de Assis, R. R., Jasinskas, A., Goldblatt, D., Felgner, P. L., Weckbecker, G., & Brown, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.611661 · Cited by 15
Sattler, C., Hoffmann, P., Herzberg, P. Y., Weber, D., Holler, B., Fehn, U., Plentz, A., Beckhove, P., Winkler, J., Edinger, M., et al. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.04.052 · Cited by 15
Becker, J., Ferreira, L. C., Damasceno, A., Bichuetti, D. B., Christo, P. P., Callegaro, D., Lana–Peixoto, M. A., Sousa, N. A. D. C., de Almeida, S. M., Adoni, T., et al. (2021) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x-anp-2021-0162 · Cited by 14
Immunization in patients with inflammatory rheumatic diseases
Thomas, Κ., & Vassilopoulos, D. (2016) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2016.10.009 · Cited by 14
Luitel, P., Vais, D., & Gidron, A. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab335 · Cited by 14
Liang, Y., Meng, F., Pan, H., & Ye, D. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1009337 · Cited by 13
Piekarska, A., Giebel, S., Basak, G. W., Dybko, J., Hałaburda, K., Hus, I., Karakulska‐Prystupiuk, E., Jakubas, B., Mensah‐Glanowska, P., Rzepecki, P., et al. (2017) · Acta Haematologica Polonica · doi:10.1016/j.achaem.2017.01.003 · Cited by 10
Advancing Biologic Therapy for Refractory Autoimmune Hepatitis
Czaja, A. J. (2022) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-07378-4 · Cited by 10
Terada, M., Kondo, N., Wanifuchi‐Endo, Y., Fujita, T., Asano, T., Hisada, T., Uemoto, Y., Kato, A., Yamanaka, N., Sugiura, H., et al. (2022) · Breast Cancer Research and Treatment · doi:10.1007/s10549-022-06693-2 · Cited by 11
Vaccination in patients under monoclonal antibody treatment: an updated comprehensive review
Rivera‐Izquierdo, M., Valero-Ubierna, M. D. C., Nieto-Gómez, P., Martínez-Bellón, M. D., Fernández‐Martínez, N. F., & Quintana, J. L. B. (2020) · Expert Review of Vaccines · doi:10.1080/14760584.2020.1800462 · Cited by 10
Infection risk in autoimmune hematological disorders with low‐dose rituximab treatment
Wang, H., Yan, S., Liu, H., Li, L., Song, J., Wang, G., Wang, H., Wu, Y., Shao, Z., & Fu, R. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23455 · Cited by 8
Natural IgM antibodies in the immune defence against neoehrlichiosis
Wennerås, C., Goldblatt, D., Zancolli, M., Mattsson, M., Wass, L., Hörkkö, S., & Rosén, A. (2017) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2017.1347815 · Cited by 8
Rituximab for the Treatment of Follicular Lymphoma
Cheah, C. Y., Lingaratnam, S. M., & Seymour, J. F. (2013) · Future Oncology · doi:10.2217/fon.13.134 · Cited by 8
Bertozzi, A., Mariottini, A., Marchi, L., Cristinzi, M. D., Nistri, R., Damato, V., Mechi, C., Barilaro, A., Massacesi, L., & Repice, A. M. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104582 · Cited by 7
Chong, E. A., Kumashie, K. G., Chong, E. R., Fabrizio, J., Gupta, A., Svoboda, J., Barta, S. K., Walsh, K. M., Napier, E. B., Lundberg, R. K., et al. (2024) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiae106 · Cited by 7
Self-citationTöllner, M., Speer, C., Benning, L., Bartenschlager, M., Nußhag, C., Morath, C. P., Zeier, M., Süsal, C., Schnitzler, P., Schmitt, W. H., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11061739 · Cited by 7
Clemente, D., Cuadros, E. N., Lovillo, M. C., Calzada‐Hernández, J., Martín, S. G., Silveira, L. F., Lirola, M. J., Tagarro, A., Alcobendas, R., López, A. L., et al. (2023) · European Journal of Pediatrics · doi:10.1007/s00431-023-05080-3 · Cited by 6
Immune Compromise Associated with Biologics
Eisenberg, R. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405546-9.00049-2 · Cited by 7
Self-citationColombo, D., Gatti, A., Alabardi, P., Bompane, D., Bonardi, G., Mumoli, N., Faggioli, P. M., Clerici, P., Brando, B., & Mazzone, A. (2022) · Journal of Hematology · doi:10.14740/jh845 · Cited by 6
Multi-Omics Studies towards Novel Modulators of Influenza A Virus-Host InteractionPreprint
Söderholm, S., Fu, Y., Gaelings, L., Belanov, S., Yetukuri, L., Berlinkov, M. V., Cheltov, A. V., Anders, S., Aittokallio, T. A., Nyman, T. A., et al. (2016) · Preprints.org · doi:10.20944/preprints201608.0054.v1 · Cited by 6
Rivera‐Izquierdo, M., Morales-Portillo, A., de Alba, I. G.-F., Fernández‐Martínez, N. F., Schoenenberger-Arnaiz, J. A., Quintana, J. L. B., & Valero-Ubierna, C. (2024) · Expert Review of Vaccines · doi:10.1080/14760584.2024.2401839 · Cited by 5
Ofatumumab subcutaneous injection for the treatment of relapsing forms of multiple sclerosis
Costa, G. D., Leocani, L., & Comi, G. (2022) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2022.2031982 · Cited by 5
Hagihara, M., Imai, Y., Uchida, T., Ohara, S., Inoue, M., Sugi, T., & Mitamura, K. (2022) · Internal Medicine · doi:10.2169/internalmedicine.9513-22 · Cited by 5
Insight in booster COVID-19 vaccine and disease modifying therapy in multiple sclerosis
Beard, K., & Sriwastava, S. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.120034 · Cited by 6
Wang, X., Patel, C., Sharma, K., Giles, M., Burns, P. L., Macartney, K. K., Flanagan, K. L., Teh, B. W., & Williams, P. C. (2026) · Vaccine · doi:10.1016/j.vaccine.2026.128399 · Cited by 4
Azar, J. H., Evans, J. P., Sikorski, M., Chakravarthy, K. B., McKenney, S., Carmody, I., Zeng, C., Teodorescu, R., Song, N., Hamon, J. L., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.163434 · Cited by 4
Kuwait Recommendations on Vaccine Use in People with Inflammatory Rheumatic Diseases
Alenizi, A., Alsaeid, K., Al-Awadhi, A. M., Hasan, E., Husain, E. H., Alfadhli, A., Ghanem, A., Abutiban, F., Ali, Y. M., Al-Herz, A. A., et al. (2018) · International Journal of Rheumatology · doi:10.1155/2018/5217461 · Cited by 4
Fujii, T., Hagihara, M., Mitamura, K., Nakashima, S., Ohara, S., Uchida, T., Inoue, M., Okuda, M., Yasuhara, A., Murakami, J., et al. (2022) · Internal Medicine · doi:10.2169/internalmedicine.9209-21 · Cited by 4
Torres, M., Corona, M., Rodríguez-Mora, S., Casado‐Fernández, G., Zurdo-Castronuño, A., Mateos, E., Ramos-Martín, F., Sánchez-Menéndez, C., Murciano-Antón, M. A., García‐Pérez, J., et al. (2022) · Cancers · doi:10.3390/cancers14225537 · Cited by 5
Ren, J., Wang, J., Liu, R., Guo, J., Yao, Y., Luo, J., Hao, H.-J., & Gao, F. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1152992 · Cited by 4
Machine learning analysis of humoral and cellular responses to SARS-CoV-2 infection in young adults
Marcinkevičs, R., Silva, P. N., Hankele, A., Dörnte, C., Kadelka, S., Csik, K., Godbersen, S., Goga, A., Hasenöhrl, L., Hirschi, P., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1158905 · Cited by 4
Ishida, H., Furusawa, M., Unagami, K., Omoto, K., Iizuka, J., & Takagi, T. (2022) · Experimental and Clinical Transplantation · doi:10.6002/ect.2022.0020 · Cited by 4
Shimizu, A., Shirai, I., Ogawa, K., Miura, A., Haruhara, K., Oshiro, K., Hamaguchi, A., Yokote, S., Okabe, M., Ueda, H., et al. (2022) · Internal Medicine · doi:10.2169/internalmedicine.0241-22 · Cited by 4
Rasmussen, S. L., Kumar, P., Trebbien, R., Leutscher, P. D. C., & Rasmussen, C. (2023) · European Journal of Rheumatology · doi:10.5152/eurjrheum.2023.23053 · Cited by 3
Metadata
- Authors
- Eisenberg, R. A., Jawad, A. F., Boyer, J., Maurer, K., McDonald, K., Prak, E. T. L., & Sullivan, K. E.
- Affiliations
- University of Pennsylvania (US)
- Children's Hospital of Philadelphia (US)
- Abramson Cancer Center (US)
- Corresponding author
- Sullivan, Kathleen E
- Venue
- Journal of Clinical Immunology
- Published
- 2012-10-14
- Volume
- 33
- Issue
- 2
- Pages
- 388-396
- ISSN
- 0271-9142 (ISSN-L)
- 1573-2592
- PMC
- PMC3565069
- OpenAlex
- W1977749342
- Cited by
- 126
- References
- 63
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 3 · 2023: 11 · 2022: 20 · 2021: 31 · 2020: 8 · 2019: 3 · 2018: 3 · 2017: 7 · 2016: 10 · 2015: 5 · 2014: 7 · 2013: 7
- FWCI
- 4.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Clinical Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (n01ai50024-7-0-1)
- National Cancer Institute (P30CA016520)
- National Institute of Allergy and Infectious Diseases (N01-AI-50024, R01AI063626, N01 AI050024)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR034156)
- Topics
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Keywords
- rituximab, influenza vaccination, vaccine response, B-cell depletion, B cell recovery, T cell subsets, humoral immunity, rheumatic diseases, hemagglutination inhibition, antibody response
- MeSH terms
- Rituximab, Adult, Aged, Antibodies, Viral, B-Lymphocytes, Female, Humans, Immunoglobulin G, Immunologic Memory, Influenza, Human, Influenza Vaccines, Lymphocyte Depletion, Male, Middle Aged, Rheumatic Diseases, T-Lymphocyte Subsets, Antirheumatic Agents, Lymphocyte Count, Antigens, CD19, Immunity, Humoral, Antibodies, Monoclonal, Murine-Derived
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
